论文信息 - Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision - 字舞流文

Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision

C. London | P. Bergman | J. Boucher | G. Mauldin | C. Henry | M. Rosenberg | M. Klein | Guillermo Couto | K. Mitchener | G. Michels | A. Rusk | P. B. Malpas | S. Wood-Follis | John G. Hintermeister | Guillermo C. Couto | G. N. Mauldin | Phyllis B. Malpas